Mucolytic activity of bacterial and human chitinases

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 5, 2007, Pages 839-846

  Sanders, Niek N ^a   Eijsink, Vincent G H ^b   van den Pangaart, Petra S ^c   Joost van Neerven, R J ^c   Simons, Peter J ^c   De Smedt, Stefaan C ^a   Demeester, Joseph ^a  

^a GHENT UNIVERSITY   (Belgium)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^c Macrozyme BV   (Netherlands)

Author keywords

Chitinase; Cystic fibrosis; Mucin; Mucus; Respiratory disease

Indexed keywords

BACTERIAL ENZYME; CHITINASE; MUCIN; NUCLEASE; PROTEINASE; RECOMBINANT ENZYME;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ELECTROPHORETIC MOBILITY; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MUCOLYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; SPUTUM ANALYSIS; VISCOELASTICITY;

BACTERIA; CELL LINE, TUMOR; CHITINASE; COLORECTAL NEOPLASMS; CYSTIC FIBROSIS; DEOXYRIBONUCLEASES; DRUG CONTAMINATION; DRUG INTERACTIONS; ELASTICITY; GALLBLADDER; HUMANS; MUCINS; PEPTIDE HYDROLASES; RECOMBINANT PROTEINS; SPUTUM; VISCOSITY;

BACTERIA (MICROORGANISMS);

EID: 33947125093     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.01.011     Document Type: Article

References (46)

1. Zhu Z., Zheng T., Homer R.J., Kim Y.K., Chen N.Y., Cohn L., Hamid Q., and Elias J.A. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304 (2004) 1678-1682
2. Boot R.G., Blommaart E.F., Swart E., Ghauharali-van der vlugt K., Bijl N., Moe C., Place A., and Aerts J.M. Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J. Biol. Chem. 276 (2001) 6770-6778
3. Strous G.J., and Dekker J. Mucin-type glycoproteins. Crit. Rev. Biochem. Mol. Biol. 27 (1992) 57-92
4. Lamblin G., Degroote S., Perini J.M., Delmotte P., Scharfman A.E., Davril M., Lo-Guidice J.M., Houdret N., Dumur V., Klein A., and Roussel P. Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis. Glycoconjugate J. 18 (2001) 661-684
5. Patil R.S., Ghormade V., and Deshpande M.V. Chitinolytic enzymes: an exploration. Enzyme Microb. Technol. 26 (2000) 473-483
6. Sorbotten A., Horn S.J., Eijsink V.G.H., and Varum K.M. Degradation of chitosans with chitinase B from Serratia marcescens - production of chito-oligosaccharides and insight into enzyme processivity. FEBS J. 272 (2005) 538-549
7. Horn S.J., Sorbotten A., Synstad B., Sikorski P., Sorlie M., Varum K.M., and Eijsink V.G.H. Endo/exo mechanism and processivity of family 18 chitinases produced by Serratia marcescens. FEBS J. 273 (2006) 491-503
8. Argueso P., Herreras J.M., Calonge M., Citores L., Pastor J.C., and Girbes T. Analysis of human ocular mucus: effects of neuraminidase and chitinase enzymes. Cornea 17 (1998) 200-207
9. King M., and Rubin B.K. Pharmacological approaches to discovery and development of new mucolytic agents. Adv. Drug Delivery Rev. 54 (2002) 1475-1490
10. Rogers D.F. Mucoactive drugs for asthma and COPD: any place in therapy?. Expert Opin. Investig. Drugs 11 (2002) 15-35
11. Hays S.R., and Fahy J.V. The role of mucus in fatal asthma. Am. J. Med. 115 (2003) 68-69
12. Melton L. Does mucus hypersecretion matter in airway disease?. Lancet 359 (2002) 1924
13. Yuta A., and Baraniuk J.N. Therapeutic approaches to mucus hypersecretion. Curr. Allergy Asthma Rep. 5 (2005) 243-251
14. Vestbo J., Prescott E., and Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Am. J. Respir. Crit. Care Med. 153 (1996) 1530-1535
15. Robinson M., and Bye P.T. Mucociliary clearance in cystic fibrosis. Pediatr. Pulmonol. 33 (2002) 293-306
16. Kuyper L.M., Pare P.D., Hogg J.C., Lambert R.K., Ionescu D., Woods R., and Bai T.R. Characterization of airway plugging in fatal asthma. Am. J. Med. 115 (2003) 6-11
17. Suri R. The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis. BioDrugs 19 (2005) 135-144
18. App E.M., Baran D., Dab I., Malfroot A., Coffiner M., Vanderbist F., and King M. Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis. Eur. Respir. J. 19 (2002) 294-302
19. Bollert F.G.E., Paton J.Y., Marshall T.G., Calvert J., Greening A.P., and Innes J.A. Recombinant DNase in cystic fibrosis: a protocol for targeted introduction through n-of-1 trials. Eur. Respir. J. 13 (1999) 107-113
20. Sanders N.N., Franckx H., De Boeck K., Haustraete J., De Smedt S.C., and Demeester J. Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis. Thorax 61 (2006) 962-968
21. Stockley R.A. New approaches to the management of COPD. Chest 117 (2000) 58S-62S
22. Pauwels R.A. National and international guidelines for COPD: the need for evidence. Chest 117 (2000) 20S-22S
23. Colina A.R., Aumont F., Deslauriers N., Belhumeur P., and de Repentigny L. Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect. Immun. 64 (1996) 4514-4519
24. Connaris S., and Greenwell P. Glycosidases in mucin-dwelling protozoans. Glycoconjugate J. 14 (1997) 879-882
25. Bisaillon M., Senechal S., Bernier L., and Lemay G. A glycosyl hydrolase activity of mammalian reovirus sigma1 protein can contribute to viral infection through a mucus layer. J. Mol. Biol. 286 (1999) 759-773
26. Berry M., Harris A., Lumb R., and Powell K. Commensal ocular bacteria degrade mucins. Br. J. Ophthalmol. 86 (2002) 1412-1416
27. Loiseau P.M., Bories C., and Sanon A. The chitinase system from Trichomonas vaginalis as a potential target for antimicrobial therapy of urogenital trichomoniasis. Biomed. Pharmacother. 56 (2002) 503-510
28. Olmsted S.S., Meyn L.A., Rohan L.C., and Hillier S.L. Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis. Sex. Transm. Dis. 30 (2003) 257-261
29. Renkema G.H., Boot R.G., Muijsers A.O., Donker-Koopman W.E., and Aerts J.M. Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins. J. Biol. Chem. 270 (1995) 2198-2202
30. Boot R.G., Renkema G.H., Strijland A., van Zonneveld A.J., and Aerts J.M. Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J. Biol. Chem. 270 (1995) 26252-26256
31. Fusetti F., von Moeller H., Houston D., Rozeboom H.J., Dijkstra B.W., Boot R.G., Aerts J.M., and van Aalten D.M. Structure of human chitotriosidase. Implications for specific inhibitor design and function of mammalian chitinase-like lectins. J. Biol. Chem. 277 (2002) 25537-25544
32. Brurberg M.B., Eijsink V.G.H., and Nes I.F. Characterization of a chitinase gene (ChiA) from Serratia marcescens BJl200 and one-step purification of the gene product. FEMS Microbiol. Lett. 124 (1994) 399-404
33. Brurberg M.B., Eijsink V.G.H., Haandrikman A.J., Venema G., and Nes I.F. Chitinase-B from Serratia marcescens BJl200 is exported to the periplasm without processing. Microbiology 141 (1995) 123-131
34. Brurberg M.B., Nes I.F., and Eijsink V.G.H. Comparative studies of chitinases A and B from Serratia marcescens. Microbiology 142 (1996) 1581-1589
35. Klomp L.W.J., Delely A.J., and Strous G.J. Biosynthesis of a human gallbladder mucin. Biochem. J. 304 (1994) 737-744
36. Sanders N.N., De Smedt S.C., Van Rompaey E., Simoens P., De Baets F., and Demeester J. Cystic fibrosis sputum-A barrier to the transport of nanospheres. Am. J. Respir. Crit. Care Med. 162 (2000) 1905-1911
37. Kunitz M. Crystalline desoxyribonuclease I. Isolation and general properties; spectrophotometric method for the measurement of desoxyribonuclease activity. J. Gen. Physiol. 33 (1950) 349-362
38. Benedik M.J., and Strych U. Serratia marcescens and its extracellular nuclease. FEMS Microbiol. Lett. 165 (1998) 1-13
39. Zhao J., Zhu H., Wong C.H., Leung K.Y., and Wong W.S.F. Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach. Proteomics 5 (2005) 2799-2807
40. Folders J., Algra J., Roelofs M.S., van Loon L.C., Tommassen J., and Bitter W. Characterization of Pseudomonas aeruginosa chitinase, a gradually secreted protein. J. Bacteriol. 183 (2001) 7044-7052
41. Xia B.Y., Royall J.A., Damera G., Sachdev G.P., and Cummings R.D. Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis. Glycobiology 15 (2005) 747-775
42. Fuchs R.L., Mcpherson S.A., and Drahos D.J. Cloning of a Serratia marcescens gene encoding chitinase. Appl. Environ. Microbiol. 51 (1986) 504-509
43. Twumasi D.Y., and Liener I.E. Proteases from purulent sputum-purification and properties of elastase and chymotrypsin-like enzymes. J. Biol. Chem. 252 (1977) 1917-1926
44. Venaille T.J., Ryan G., and Robinson B.W.S. Epithelial cell damage is induced by neutrophil-derived, not Pseudomonas-derived, proteases in cystic fibrosis sputum. Respir. Med. 92 (1998) 233-240
45. Gaseidnes S., Synstad B., Jia X.H., Kjellesvik H., Vriend G., and Eijsink V.G.H. Stabilization of a chitinase from Serratia marcescens by Gly → Ala and Xxx → Pro mutations. Protein Eng. 16 (2003) 841-846
46. Hinrichs W.L.J., Prinsen M.G., and Frijlink H.W. Inulin glasses for the stabilization of therapeutic proteins. Int. J. Pharm. 215 (2001) 163-174